Thursday, April 8, 2010

BIOMEDevice Executive Forum

Are you looking for new ways to achieve the innovation necessary to deal with increased regulatory scrutiny, patent expirations, higher levels of generic competition, and an aging population? Learn from the top corporate industry experts, who've revolutionized their processes, how to embrace disruption to confront these enormous challenges.

Convergent medical technologies are redefining the life science sector with technologies that allow for improved medical outcomes, improved safety, and decreased healthcare costs.

Hear disruptive innovative solutions from the Forum's distinguished speaking faculty:
  • Edward Abrahams, PhD, Executive Director, Personalized Medicine Coalition
  • George C Avgerinos, PhD, Sr. Director, Humira Technical Operations, Global Pharmaceutical Operations, Abbott Biotechnology
  • Lee Babiss, former President Pharmaceuticals, Roche
  • Susan Windham-Bannister, CEO & President, Massachusetts Life Sciences Center
  • Abi Barrow, Executive Director, Massachusetts Technology Transfer Center
  • Steve Bushnell, PhD, Sr. Director, Discovery Translational Medicine, Biogen Idec
  • Zen Chu, Founder, Accelerated Medical Ventures
  • Natalie Cummins, Vice President, DHC Consulting
  • David Dykeman, Shareholder, Greenberg Traurig
  • Axel Erhard, Vice President, ATKearney
  • Amy Fredrick, Director, Medtech Ignite, MassMEDIC
  • Susan Garfield, Vice President, BridgeHead International
  • Mark Grinstaff, PhD, MD, Boston University, CIMIT, Co-Founder Affinergy
  • Gary Gustavsen, Associate, Personalized Medicine Initiative, Health Advances
  • Mike Hammon, Infinty InfoSystems
  • Josh Hamermesh, Sr. Vice President, Strategy & Corporate Development
  • Pervasis Therapeutics, Inc.
  • Michael Hess, Vice President, Innovation, Medtronic, Inc.
  • Terry Hisey, Vice Chairman & US Life Science Leader, Deloitte
  • Christopher Loose, PhD, Chief Technology Officer, Semprus BioSciences
  • John McDonough, CEO, T2 BioSystems, Inc.
  • Iain Miller, PhD, Executive Director, Theranostics Strategy and Business Development, Biomerieux
  • Imrah Nasrullah, Chief Business Officer, Massachusetts Biotechnology Council
  • Kristin Pothier, Vice President, Diagnostics and Discovery Tools Practice, Health Advances
  • John Ridge, Director Reimbursement Services, Ventana Medical Systems, a Roche Diagnostics Company
  • Dean Tozer, Sr. Vice President, Advanced BioHealing
  • Monique Yoakim-Turk, PhD, Technology Development, Technology and Innovation Development Office, Children's Hospital Boston
  • Miguel Velez, Global Director, Procurement, Merck
Learn more here:

No comments:

Post a Comment